Thin Film Drug Manufacturing Market

Thin Film Drug Manufacturing Market (Product - Oral Thin Film (Sublingual Film and Fully Dissolving Dental/Buccal Film), and Transdermal Thin Film; Disease Indication - Schizophrenia, Migraine, Opioid Dependence, and Nausea and Vomiting; Distribution Channel - Hospital Pharmacies, Drug Store, Retail Pharmacies, and E-Commerce) - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2016 - 2024

  • Rep Id : TMRGL11525
  • Published On : May 2017
  • No. of Pages : 197
  • Category : Pharmaceutical

1. Preface 
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology 

3. Executive Summary

4. Market Overview
     4.1. Introduction
            4.1.1. Product Definition
            4.1.2. Industry Evolution / Developments
     4.2. Overview
     4.3. Key Market Indicators
     4.4. Market Dynamics
            4.4.1. Drivers
            4.4.2. Restraints
            4.4.3. Opportunity 
     4.5. Global Thin Film Drug Manufacturing  Analysis and Forecasts, 2016–2024
     4.6. Thin Film Drug Manufacturing  - Global Supply Demand Scenario
     4.7. Porter’s Five Force Analysis
     4.8. Value Chain Analysis
     4.9. Market Outlook

5.  Global Thin Film Drug Manufacturing  Analysis and Forecasts, By Product
     5.1. Introduction & Definition
     5.2. Key Findings / Developments
     5.3. Key Trends
     5.4. Market Value Forecast By Product, 2016–2024
            5.4.1. Oral Thin Film
                     5.4.1.1. Sublingual film
                     5.4.1.2. Fully dissolving dental/ buccal film
            5.4.2. Transdermal Thin Film
            5.4.3. Others
     5.5. Product  Comparison Matrix
     5.6. Market Attractiveness By Product
     5.7. Oral Thin Film Drugs : Key market insights
            5.7.1. Pipeline Analysis
            5.7.2. Technology Insights
            5.7.3. Key Product Insights

6. Global Thin Film Drug Manufacturing  Analysis and Forecasts, By Distribution Channel
     6.1. Introduction & Definition
     6.2. Key Findings
     6.3. Market Value Forecast By Distribution Channel, 2016–2024
            6.3.1. Hospital Pharmacies
            6.3.2.  Drug Stores
            6.3.3. Retail Pharmacies
            6.3.4. E- Commerce
     6.4. Distribution Channel  Comparison Matrix
     6.5. Market Attractiveness By Distribution Channel 

7. Global Thin Film Drug Manufacturing  Analysis and Forecasts, By Disease Indication
     7.1. Introduction & Definition
     7.2. Key Findings
     7.3. Key Trends
     7.4. Market Value Forecast By Disease Indication, 2016–2024
            7.4.1. Schizophrenia
            7.4.2. Migraine
            7.4.3. Opioid Dependence
            7.4.4. Nausea & Vomiting
            7.4.5. Others
     7.5. Disease Indication Comparison Matrix
     7.6. Market Attractiveness By Disease Indication

8. Global Thin Film Drug Manufacturing  Analysis and Forecasts, By Region
     8.1. Introduction & Definition
     8.2. Key Findings
     8.3. Market Value Forecast By Region
            8.3.1. North America
            8.3.2. Latin America 
            8.3.3. Asia Pacific
            8.3.4. Europe
            8.3.5. Middle East & Africa
     8.4. Market Attractiveness By Country/Region

9. North America Thin Film Drug Manufacturing  Analysis and Forecast
     9.1. Introduction
     9.2. Market Value Forecast By Product, 2016–2024
            9.2.1. Oral Thin Film
                     9.2.1.1. Sublingual film
                     9.2.1.2. Fully dissolving dental/ buccal film
            9.2.2. Transdermal Thin Film
            9.2.3. Others (Ocular Thin Film, etc.)
     9.3. Market Value Forecast By Distribution Channel, 2016–2024
            9.3.1. Hospital Pharmacies
            9.3.2. Drug Stores
            9.3.3. Retail Pharmacies
            9.3.4. E- Commerce
     9.4. Market Value Forecast By Disease Indication, 2016–2024
            9.4.1. Schizophrenia
            9.4.2. Migraine
            9.4.3. Opioid Dependence
            9.4.4. Nausea & Vomiting
            9.4.5. Others
     9.5. Market Value Forecast By Country, 2016–2024
            9.5.1. U.S.
            9.5.2. Canada
     9.6. Market Attractiveness Analysis 
            9.6.1. By Product
            9.6.2. By Distribution Channel
            9.6.3. By Disease Indication
            9.6.4. By Country

10. Latin America Thin Film Drug Manufacturing  Analysis and Forecast
     10.1. Introduction
     10.2. Market Value Forecast By Product, 2016–2024
            10.2.1. Oral Thin Film
                     10.2.1.1. Sublingual film
                     10.2.1.2. Fully dissolving dental/ buccal film
            10.2.2. Transdermal Thin Film
            10.2.3. Others (Ocular Thin Film, etc.)
     10.3. Market Value Forecast By Distribution Channel, 2016–2024
            10.3.1. Hospital Pharmacies
            10.3.2. Drug Stores
            10.3.3. Retail Pharmacies
            10.3.4. E- Commerce
     10.4. Market Value Forecast By Disease Indication, 2016–2024
            10.4.1. Schizophrenia
            10.4.2. Migraine
            10.4.3. Opioid Dependence
            10.4.4. Nausea & Vomiting
            10.4.5. Others
     10.5. Market Value Forecast By Country, 2016–2024
            10.5.1. Brazil
            10.5.2. Mexico
            10.5.3. Rest of Latin America
     10.6. Market Attractiveness Analysis 
            10.6.1. By Product
            10.6.2. By Distribution Channel
            10.6.3. By Disease Indication
            10.6.4. By Country

11. Asia Pacific Thin Film Drug Manufacturing  Analysis and Forecast
     11.1. Introduction
     11.2. Market Value Forecast By Product, 2016–2024
            11.2.1. Oral Thin Film
                     11.2.1.1. Sublingual film
                     11.2.1.2. Fully dissolving dental/ buccal film
            11.2.2. Transdermal Thin Film
            11.2.3. Others (Ocular Thin Film, etc.)
     11.3. Market Value Forecast By Distribution Channel, 2016–2024
            11.3.1. Hospital Pharmacies
            11.3.2. Drug Stores
            11.3.3. Retail Pharmacies
            11.3.4. E- Commerce
     11.4. Market Value Forecast By Disease Indication, 2016–2024
            11.4.1. Schizophrenia
            11.4.2. Migraine
            11.4.3. Opioid Dependence
            11.4.4. Nausea & Vomiting
            11.4.5. Others
     11.5. Market Value Forecast By Country, 2016–2024
            11.5.1. Japan
            11.5.2. India
            11.5.3. China
            11.5.4. Rest Of Asia Pacific
     11.6. Market Attractiveness Analysis 
            11.6.1. By Product
            11.6.2. By Distribution Channel
            11.6.3. By Disease Indication
            11.6.4. By Country

12.  Europe Thin Film Drug Manufacturing  Analysis and Forecast
     12.1. Introduction
     12.2. Market Value Forecast By Product, 2016–2024
            12.2.1. Oral Thin Film
                     12.2.1.1. Sublingual film
                     12.2.1.2. Fully dissolving dental/ buccal film
            12.2.2. Transdermal Thin Film
            12.2.3. Others (Ocular Thin Film, etc.)
     12.3. Market Value Forecast By Distribution Channel, 2016–2024
            12.3.1. Hospital Pharmacies
            12.3.2. Drug Stores
            12.3.3. Retail Pharmacies
            12.3.4. E- Commerce
     12.4. Market Value Forecast By Disease Indication, 2016–2024
            12.4.1. Schizophrenia
            12.4.2. Migraine
            12.4.3. Opioid Dependence
            12.4.4. Nausea & Vomiting
            12.4.5. Others
     12.5. Market Value Forecast By Country, 2016–2024
            12.5.1. France
            12.5.2. Germany 
            12.5.3. Italy
            12.5.4. Spain
            12.5.5. Russia
            12.5.6. Rest Of Europe
     12.6. Market Attractiveness Analysis 
            12.6.1. By Product
            12.6.2. By Distribution Channel
            12.6.3. By Disease Indication
            12.6.4. By Country

13. Middle East & Africa Thin Film Drug Manufacturing  Analysis and Forecast
     13.1.  Introduction
     13.2. Market Value Forecast By Product, 2016–2024
            13.2.1. Oral Thin Film
                     13.2.1.1. Sublingual film
                     13.2.1.2. Fully dissolving dental/ buccal film
            13.2.2. Transdermal Thin Film
            13.2.3. Others (Ocular Thin Film, etc.)
     13.3. Market Value Forecast By Distribution Channel, 2016–2024
            13.3.1. Hospital Pharmacies
            13.3.2. Drug Stores
            13.3.3. Retail Pharmacies
            13.3.4. E- Commerce
     13.4. Market Value Forecast By Disease Indication, 2016–2024
            13.4.1. Schizophrenia
            13.4.2. Migraine
            13.4.3. Opioid Dependence
            13.4.4. Nausea & Vomiting
            13.4.5. Others
     13.5. Market Value Forecast By Country, 2016–2024
            13.5.1. South Africa
            13.5.2. Saudi Arabia
            13.5.3. UAE
            13.5.4. Rest of Middle East & Africa
     13.6. Market Attractiveness Analysis 
            13.6.1. By Product
            13.6.2. By Distribution Channel
            13.6.3. By Disease Indication
            13.6.4. By Country

14. Competition Landscape
     14.1. Market Player – Competition Matrix (By Tier and Size of companies)
     14.2. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
            14.2.1. ZIM Laboratories Limited
                     14.2.1.1. Company Details
                     14.2.1.2. Business Overview
                     14.2.1.3. Financial Overview
                     14.2.1.4. Strategic Overview
                     14.2.1.5. SWOT Analysis
            14.2.2. Indivior plc.
                     14.2.2.1. Company Details
                     14.2.2.2. Business Overview
                     14.2.2.3. Financial Overview
                     14.2.2.4. Strategic Overview
                     14.2.2.5. SWOT Analysis
            14.2.3. MonoSol Rx Allergan plc.
                     14.2.3.1. Company Details
                     14.2.3.2. Business Overview
                     14.2.3.3. Financial Overview
                     14.2.3.4. Strategic Overview
                     14.2.3.5. SWOT Analysis
            14.2.4. Sumitomo Dainippon Pharma Co., Ltd.
                     14.2.4.1. Company Details
                     14.2.4.2. Business Overview
                     14.2.4.3. Financial Overview
                     14.2.4.4. Strategic Overview
                     14.2.4.5. SWOT Analysis
            14.2.5. IntelGenx Corp
                     14.2.5.1. Company Details
                     14.2.5.2. Business Overview
                     14.2.5.3. Financial Overview
                     14.2.5.4. Strategic Overview
                     14.2.5.5. SWOT Analysis
            14.2.6. Pfizer, Inc.
                     14.2.6.1. Company Details
                     14.2.6.2. Business Overview
                     14.2.6.3. Financial Overview
                     14.2.6.4. Strategic Overview
                     14.2.6.5. SWOT Analysis
            14.2.7. Novartis AG
                     14.2.7.1. Company Details
                     14.2.7.2. Business Overview
                     14.2.7.3. Financial Overview
                     14.2.7.4. Strategic Overview
                     14.2.7.5. SWOT Analysis
            14.2.8. Allergan plc.
                     14.2.8.1. Company Details
                     14.2.8.2. Business Overview
                     14.2.8.3. Financial Overview
                     14.2.8.4. Strategic Overview
                     14.2.8.5. SWOT Analysis
            14.2.9. NAL Pharma
                     14.2.9.1. Company Details
                     14.2.9.2. Business Overview
                     14.2.9.3. Financial Overview
                     14.2.9.4. Strategic Overview
                     14.2.9.5. SWOT Analysis
            14.2.10. Wolters Kluwer
                     14.2.10.1. Company Details
                     14.2.10.2. Business Overview
                     14.2.10.3. Financial Overview
                     14.2.10.4. Strategic Overview
                     14.2.10.5. SWOT Analysis
            14.2.11. Solvay
                     14.2.11.1. Company Details
                     14.2.11.2. Business Overview
                     14.2.11.3. Financial Overview
                     14.2.11.4. Strategic Overview
                     14.2.11.5. SWOT Analysis

List of Tables

Table 01: Global Opportunity for Oral Thin Film Drugs Market (Addressable Market), Revenue (US$ Bn), Forecast 2016–2024, by Product Type
Table 02: Global Opportunity for Oral Thin Film Drugs Market (Addressable Market), Revenue (US$ Bn), Forecast 2016-2024, by Region
Table 03: Global Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Product Type,2014–2024
Table 04: Global Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Product Type,2014–2024
Table 05: Global Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Disease Indication, 2014–2024
Table 06: Global Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 07: Global Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Region, 2014–2024
Table 08: North America Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 09: North America Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 10: North America Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Product Type – Oral Thin Film, 2014–2024
Table 11: North America Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Disease Indication, 2014–2024
Table 12: North America Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 13: Latin America Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 14: Latin America Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 15: Latin America Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Product Type – Oral Thin Film, 2014–2024
Table 16: Latin America Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Disease Indication, 2014–2024
Table 17: Latin America Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 18: Asia Pacific Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 19: Asia Pacific Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 20: Asia Pacific Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 21: Asia Pacific Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Disease Indication, 2014–2024
Table 22: Asia Pacific Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 23: Europe Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 24: Europe Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 25: Europe Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 26: Europe Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Disease Indication, 2014–2024
Table 27: Europe Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 28: Middle East & Africa Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 29: Middle East & Africa Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 30: Middle East & Africa Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Product Type – Oral Thin Film, 2014–2024
Table 31: Middle East & Africa Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Disease Indication, 2014–2024
Table 32: Middle East & Africa Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, by Distribution Channel

List of Figures

Figure 01: Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, 2016–2024
Figure 03: Market Value Share (%), by Disease Indication (2015)
Figure 05: Market Value Share (%), by Region (2015)
Figure 02: Market Value Share (%), by Product Type (2015)
Figure 04: Market Value Share (%), by Distribution Channel (2015)
Figure 06: Global Thin Film Drug Manufacturing Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 07: Global Oral Thin Film Drug Market Revenue (US$ Mn), 2014–2024
Figure 08: Global Transdermal Thin Film Drug Market Revenue (US$ Mn), 2014–2024
Figure 09: Global others (ocular thin film, etc.) Market Revenue (US$ Mn), 2014–2024
Figure 10: Thin Film Drug Manufacturing Market Attractiveness Analysis, by Product Type, 2014–2024
Figure 11: Oral Thin Film Drug Manufacturing Market, Pipeline Analysis 2015
Figure 12: Oral Thin Film Drug Manufacturing Market, by Technology
Figure 13: Global Sales of Major OTF Products (US$ Thousand), 2014
Figure 14: Total SUBOXONE Film Sales (US$ Mn), 2010–2014
Figure 15: Total Onsolis & Breakyl Sales (US$ Thousand), 2011–2014
Figure 16: Total Fentanyl Product Sales (US$ Mn), 2010–2014
Figure 17: Global Thin Film Drug Manufacturing Market Value Share Analysis, by Disease Indication, 2016 and 2024
Figure 18: Global Thin Film Drug Manufacturing Market Revenue (US$ Mn) Forecast, by Schizophrenia, 2014–2024
Figure 19: Global Thin Film Drug Manufacturing Market Revenue (US$ Mn) Forecast, by Migraine, 2014–2024
Figure 20: Global Thin Film Drug Manufacturing Market Revenue (US$ Mn) Forecast, by Opioid Dependence, 2014–2024
Figure 21: Global Thin Film Drug Manufacturing Market Revenue (US$ Mn) Forecast, by Nausea & Vomiting, 2014–2024
Figure 22: Global Thin Film Drug Manufacturing Market Revenue (US$ Mn) Forecast, by Others, 2014–2024
Figure 23: Global Thin Film Drug Manufacturing Market Attractiveness Analysis, by Disease Indication, 2016-2024
Figure 24: Number of oral thin ?lm drugs by disease indication (out of total identified drugs at different drug development stages), 2015
Figure 25: Global Thin Film Drug Manufacturing Market Value Share Analysis, by Distribution Channel, 2016 and 2024
Figure 26: Thin Film Drug Manufacturing Market, by Hospital Pharmacies, Revenue (US$ Mn), 2014–2024
Figure 27: Thin Film Drug Manufacturing Market, by Drug Store, Revenue (US$ Mn), 2014–2024
Figure 28: Thin Film Drug Manufacturing Market, by Retail Pharmacies, Revenue (US$ Mn), 2014–2024
Figure 29: Thin Film Drug Manufacturing Market by E-Commerce, Revenue (US$ Mn), 2014–2024
Figure 30: Thin Film Drug Manufacturing Market Attractiveness Analysis, by Distribution Channel, 2014–2024
Figure 31: Global Thin Film Drug Manufacturing Market Value Share Analysis, by Region, 2016 and 2024
Figure 32: North America Thin Film Drug Manufacturing Market Revenue (US$ Mn), 2014–2024
Figure 33: Europe Thin Film Drug Manufacturing Market Revenue (US$ Mn), 2014–2024
Figure 34: Latin America Thin Film Drug Manufacturing Market Revenue (US$ Mn), 2014–2024
Figure 35: Asia Pacific Thin Film Drug Manufacturing Market Revenue (US$ Mn), 2014–2024
Figure 36: Middle East & Africa Thin Film Drug Manufacturing Market Revenue (US$ Mn), 2014–2024
Figure 37: Thin Film Drug Manufacturing Market Attractiveness Analysis, by Region, 2014–2024
Figure 38: North America Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, 2014–2024
Figure 39: North America Thin Film Drug Manufacturing Market Attractiveness Analysis, by Country, 2016–2024
Figure 40: North America Thin Film Drug Manufacturing Market Value Share Analysis, by Country, 2016 and 2024
Figure 41: North America Thin Film Drug Manufacturing Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 42: North America Thin Film Drug Manufacturing Market Value Share Analysis, by Disease Indication, 2016 and 2024
Figure 43: North America Thin Film Drug Manufacturing Market Value Share Analysis, by Distribution Channel, 2016 and 2024
Figure 44: North America Thin Film Drug Manufacturing Market Attractiveness Analysis, by Product Type, 2016–2024
Figure 45: North America Thin Film Drug Manufacturing Market Attractiveness Analysis, by Disease Indication, 2016–2024
Figure 46: North America Thin Film Drug Manufacturing Market Attractiveness Analysis, by Distribution Channel, 2016–2024
Figure 47: Latin America Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, 2014–2024
Figure 48: Latin America Thin Film Drug Manufacturing Market Attractiveness Analysis, by Country, 2016–2024
Figure 49: Latin America Thin Film Drug Manufacturing Market Value Share Analysis, by Country, 2016 and 2024
Figure 50: Latin America Thin Film Drug Manufacturing Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 51: Latin America Thin Film Drug Manufacturing Market Value Share Analysis, by Disease Indication, 2016 and 2024
Figure 52: Latin America Thin Film Drug Manufacturing Market Value Share Analysis, by Distribution Channel, 2016 and 2024
Figure 53: Latin America Thin Film Drug Manufacturing Market Attractiveness Analysis, by Product Type, 2016–2024
Figure 54: Latin America Thin Film Drug Manufacturing Market Attractiveness Analysis, by Disease Indication, 2016–2024
Figure 55: Latin America Thin Film Drug Manufacturing Market Attractiveness Analysis, by Distribution Channel, 2016–2024
Figure 56: Asia Pacific Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, 2014–2024
Figure 57: Asia Pacific Thin Film Drug Manufacturing Market Attractiveness Analysis, by Country, 2016–2024
Figure 58: Asia Pacific Thin Film Drug Manufacturing Market Value Share Analysis, by Country, 2016 and 2024
Figure 59: Asia Pacific Thin Film Drug Manufacturing Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 60: Asia Pacific Thin Film Drug Manufacturing Market Value Share Analysis, by Disease Indication, 2016 and 2024
Figure 61: Asia Pacific Thin Film Drug Manufacturing Market Value Share Analysis, by Distribution Channel, 2016 and 2024
Figure 62: Asia Pacific Thin Film Drug Manufacturing Market Attractiveness Analysis, by Product Type, 2016–2024
Figure 63: Asia Pacific Thin Film Drug Manufacturing Market Attractiveness Analysis, by Disease Indication, 2016–2024
Figure 64: Asia Pacific Thin Film Drug Manufacturing Market Attractiveness Analysis, by Distribution Channel, 2016–2024
Figure 65: Europe Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, 2014–2024
Figure 66: Europe Thin Film Drug Manufacturing Market Attractiveness Analysis, by Country, 2016–2024
Figure 67: Europe Thin Film Drug Manufacturing Market Value Share Analysis, by Country, 2016 and 2024
Figure 68: Europe Thin Film Drug Manufacturing Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 69: Europe Thin Film Drug Manufacturing Market Value Share Analysis, by Disease Indication, 2016 and 2024
Figure 70: Europe Thin Film Drug Manufacturing Market Value Share Analysis, by Distribution Channel, 2016 and 2024
Figure 71: Europe Thin Film Drug Manufacturing Market Attractiveness Analysis, by Product Type, 2016–2024
Figure 72: Europe Thin Film Drug Manufacturing Market Attractiveness Analysis, by Disease Indication, 2016–2024
Figure 73: Europe Thin Film Drug Manufacturing Market Attractiveness Analysis, by Distribution Channel, 2016–2024
Figure 74: Middle East & Africa Thin Film Drug Manufacturing Market Size (US$ Mn) Forecast, 2014–2024
Figure 75: Middle East & Africa Thin Film Drug Manufacturing Market Attractiveness Analysis, by Country, 2016–2024
Figure 76: Middle East & Africa Thin Film Drug Manufacturing Market Value Share Analysis, by Country, 2016 and 2024
Figure 77: Middle East & Africa Thin Film Drug Manufacturing Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 78: Middle East & Africa Thin Film Drug Manufacturing Market Value Share Analysis, by Disease Indication, 2016 and 2024
Figure 79: Middle East & Africa Thin Film Drug Manufacturing Market Value Share Analysis, by Distribution Channel, 2016 and 2024
Figure 80: Middle East & Africa Thin Film Drug Manufacturing Market Attractiveness Analysis, by Product Type, 2016–2024
Figure 81: Middle East & Africa Thin Film Drug Manufacturing Market Attractiveness Analysis, by Disease Indication, 2016–2024
Figure 82: Middle East & Africa Thin Film Drug Manufacturing Market Attractiveness Analysis, by Distribution Channel, 2016–2024

.